The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human phase 1 trial of the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of WSD0922-Fu: Initial report from dose escalation cohort.
 
Sani Haider Kizilbash
Consulting or Advisory Role - Sichuan Honghe Biotechnology Co. (Inst); SK Life Sciences (Inst)
Research Funding - Apollomics (Inst); Celgene (Inst); Incyte (Inst); Loxo (Inst); Nerviano Medical Sciences (Inst); Orbus Therapeutics (Inst); Wayshine Biopharma (Inst)
 
Kurt A. Jaeckle
Stock and Other Ownership Interests - Entegrion
 
Maciej M. Mrugala
No Relationships to Disclose
 
Jacob B. Allred
No Relationships to Disclose
 
Stephanie L. Safgren
No Relationships to Disclose
 
Anita Aracelli Lammers
No Relationships to Disclose
 
Wei Zhong
Employment - Wayshine Biopharma
 
Konstantinos Leventakos
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Janssen Oncology (Inst); Jazz Pharmaceuticals (Inst); Mirati Therapeutics (Inst); MJH Life Sciences (Inst); OncLive (Inst); Regeneron (Inst); Takeda (Inst); Targeted Oncology (Inst)
Research Funding - AstraZeneca (Inst); Mirati Therapeutics (Inst)
 
Aaron Scott Mansfield
Honoraria - Roche
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Janssen (Inst)
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Abbvie; Roche
Other Relationship - Mesothelioma Applied Research Foundation
 
Mohamed Shanshal
No Relationships to Disclose
 
Wen Wee Ma
Consulting or Advisory Role - Kodikaz Therapeutic Solutions
Research Funding - Actuate Therapeutics (Inst); Athenex (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Cardiff Oncology (Inst); CUE Biopharma (Inst); Elucida Oncology (Inst); Genentech (Inst); Ipsen (Inst); Jacobio (Inst); Merus (Inst); Repare Therapeutics (Inst); Sun Pharma (Inst)
 
Joon H. Uhm
Honoraria - Novocure
Consulting or Advisory Role - Novocure
Travel, Accommodations, Expenses - Novocure
 
Jian Li Campian
Consulting or Advisory Role - Alexion Pharmaceuticals; Arbor Pharmaceuticals; Dova Pharmaceuticals; Incyte; Inovio Pharmaceuticals
Speakers' Bureau - Abbvie (I)
Research Funding - NeoImmuneTech
Travel, Accommodations, Expenses - NantWorks
 
Michael W. Ruff
No Relationships to Disclose
 
Ugur Sener
Research Funding - Mayo Clinic
 
Evanthia Galanis
Consulting or Advisory Role - Gradalis; Karyopharm Therapeutics (Inst); KIYATEC; MedImmune (Inst); SERVIER (Inst)
Research Funding - Celgene (Inst); MedImmune (Inst); SERVIER (Inst); TRACON Pharma (Inst)
 
Terry C Burns
No Relationships to Disclose
 
Caterina Giannini
No Relationships to Disclose
 
Jann Nagina Sarkaria
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Travecta Therapeutics
Research Funding - Abbvie; AstraZeneca; Bayer; Black Diamond Therapeutics; Boehringer Ingelheim; Boston Scientific; Bristol-Myers Squibb/Celgene; FORMA Therapeutics; GlaxoSmithKline; Karyopharm Therapeutics; Wayshine Biopharma
 
Alex A. Adjei
Consulting or Advisory Role - EMD Serono; Janssen; Mirati Therapeutics; Swiss Rockets; Zai Lab
Research Funding - Bayer Schering Pharma (Inst); I-Mab (Inst); Jacobio (Inst); Kura Oncology (Inst); Merck KGaA (Inst); Tesaro (Inst); Zai Lab (Inst)
(OPTIONAL) Uncompensated Relationships - Merck KGaA; Swiss Rockets; Zai Lab